최고 CCO 팟캐스트 (2024)

1
Available and Emerging Therapies for Progressive/Recurrent ROS1-Altered Advanced NSCLC 13:53

1d ago13:53

13:53

In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the available and emerging clinical data for second-line and beyond treatments in patients with recurrent ROS1-altered advanced NSCLC including: Assessing ROS1-TKI resistance mutations with tumor and liquid biopsies in patients with ROS1-altered advan…

1
Integrating New Data From AIDS 2024: Pharmacist Perspectives 18:22

8d ago18:22

18:22

In this episode, Jennifer Cocohoba, PharmD, AAHIVP, and David Koren, PharmD, MPH, AAHIVP, FIDSA, cover the most impactful LA ART and LA PrEP clinical studies presented at AIDS 2024, including: The PURPOSE 1 study of twice-yearly lenacapavir injections vs daily oral tenofovir as PrEP in cisgender women An open-label extension of HPTN 084 evaluating …

1
Expert Discussions: Novel Agents Targeting Residual Inflammatory Risk in ASCVD and CKD 15:28

12d ago15:28

15:28

In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they discuss new and emerging therapies designed to target residual inflammatory risk associated with ASCVD and CKD.    Episode outline:   Colchicine: inhibition of NLRP3 inflammasome assembly/…

1
What’s New in the Treatment of Rett Syndrome? 34:17

24d ago34:17

34:17

In this episode, David N. Lieberman, MD, PhD, and Eric Marsh, MD, PhD, discuss recent updates relevant to the treatment of Rett syndrome, including: The recently updated Comprehensive Care Guidelines from the International Rett Syndrome Foundation, available at rettsyndrome.org Ongoing collection and analysis of longitudinal data within the Rett Sy…

1
Stacey Tank's Path From CCO to CEO 36:14

26d ago36:14

36:14

In this episode, we’re joined by Stacey Tank, former CCO, Page member and the founder of this podcast, about her new role as CEO of a rising beauty brand. She recounts the path she took to become a CEO, and what skills were essential as she moved from CCO to Chief Transformation Officer, among other roles. We hope you enjoy this conversation as muc…

1
Available Clinical Data and Approved First-line Treatments for ROS1-Altered Advanced NSCLC 13:46

2d ago13:46

13:46

In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the available clinical data in support of frontline treatments for ROS1-altered NSCLC including: Efficacy and safety data for crizotinib, entrectinib, and repotrectinib in patients with ROS1-altered advanced NSCLC Long-term safety observations for cri…

1
ROS1-Alterations and Molecular Testing in Advanced NSCLC 16:28

10d ago16:28

16:28

In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the current understanding of ROS1 rearrangements in non-small-cell lung cancer tumor biology and its implications for molecular testing and treatment selection including: ROS1-gene fusions in advanced lung cancer ROS1 testing recommendations with DNA …

1
How to Make PTSD and Trauma Care an Integral Part of HIV Care 38:27

12d ago38:27

38:27

In this episode, Tristan J. Barber, MA, MD, FRCP, and Glenn J. Treisman, MD, PhD, discuss the importance of screening, diagnosing, and treating PTSD in people with HIV. They illustrate their discussion through a patient case and provide strategies for accomplishing this, sharing their own experiences and approaches to thinking about PTSD, structuri…

1
Expert Discussions on Residual Systemic Inflammation in ASCVD and CKD 14:32

12d ago14:32

14:32

In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they explore new and emerging strategies to target residual risk associated with systemic inflammation in patients with ASCVD and CKD.    Episode outline:   The relationship among systemic infl…

1
Expert Discussions: Moving Beyond Lipid Lowering to Lower Risk in ASCVD and CKD 14:32

12d ago14:32

14:32

In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they explore the pathophysiology and novel therapeutic strategies to target residual inflammatory risk associated with ASCVD and CKD.    Episode outline:   Moving beyond lipid lowering to addre…

1
Be an Ally: How to Improve Care for Transgender Persons Living With HIV 37:21

16d ago37:21

37:21

In this episode, Colleen F. Kelley, MD, MPH, and Jemma Samitpol discuss key considerations to improve the patient experience among transgender persons with HIV, including: Unique circumstances faced by transgender people trying to access HIV care (eg, stigma, discrimination) Best practices to improve access and linkage to HIV care Ways to integrate…

1
Considering Long-acting ART With Viremia and Past Adherence Challenges 40:42

17d ago40:42

40:42

In this episode featuring faculty from the United States and Europe, Aadia I. Rana, MD, and Laurence Slama, MD, PhD, discuss the subtleties of deciding among HIV treatment options in people with adherence challenges. Listen as they debate the potential risks and benefits of long-acting ART in this population, considerations for people with viremia …

1
Optimizing ART With Novel HIV Agents 12:32

22d ago12:32

12:32

In this episode, Gregory Huhn, MD, MPHTM, presents a case study of a person with a long HIV treatment history, exploring when and how to consider agents with novel mechanisms of action. Listen as he discusses: The importance of engaging with patients to understand their perspectives and improve their satisfaction with their HIV care Options in peop…

1
Making Space for HIV Care: Starting in Care 6:20

22d ago6:20

6:20

In this episode, Yvonne Gilleece, MB BCh, BAO, FRCP, uses a case study to illustrate why giving people space and time to engage in HIV care on their terms is key to overcoming potential shame and stigma. She discusses how people can be very vulnerable when engaging in HIV care, and trauma-informed care can help address these vulnerabilities in a sa…

1
Keeping Up With HBV Care: Sharing Session 4 11:41

24d ago11:41

11:41

In this episode, George Lau, MD, FRCP (Edin, Lond), FHKAM (Med), FHKCP, FAASLD, MBBS (HKU), and a patient discuss opportunities to optimize care for people living with hepatitis B virus (HBV), including: Consequences to poor adherence to antiviral therapy Strategies to promote medication adherence (eg, patient education, setting up routines) The ro…

1
Optimizing Oral ART 10:02

25d ago10:02

10:02

In this episode, Gregory Huhn, MD, presents a case study exploring how to optimize oral ART for a person with a long history of different ART regimens. Listen as he discusses: Reasons to consider regimen optimization in the setting of viral suppression Evidence for INSTIs in the setting of resistance Data on when 2-drug regimens and long-acting reg…

1
Beyond Viral Suppression—Pharmacist Perspectives 12:35

29d ago12:35

12:35

In this episode, Lucas Hill, PharmD, AAHIVP, BCACP, and Bernadette Jakeman, PharmD, PhC, BCPS, AAHIVP,discuss what pharmacists need to know to provide high-quality HIV care beyond viral suppression, including treatment strategies and tips for addressing and improving patients’ quality of life. Listen as they discuss: Reasons to consider regimen opt…

1
Sparking Courageous Conversations at Work 5:29

1M ago5:29

5:29

Holding courageous conversations in the workplace can help to advance equity, diversity, and inclusion. Learn how to start these discussions, and how they can foster greater understanding, connection, growth, and even healing. Released: August 8, 2024 File Size: 3 MB Length: 5:28 minutes ------------------------- « Sparking Courageous Conversations…

1
Midyear Highlights of Key Data From 2024 Gynecologic Cancer Conferences Informing Treatment of Ovarian, Endometrial, and Cervical Cancers 49:32

1M ago49:32

49:32

In this episode, listen to Floor J. Backes, MD, and Angeles Alvarez Secord, MD, MHSc, share their clinical insights and takeaways on new data presented for endometrial, ovarian, and cervical cancers presented at the 2024 annual meetings of the Society of Gynecologic Oncology and American Society of Clinical Oncology including: RUBY Part 1 Subgroup …

1
Paris, The Impossible City in an Impossible World 33:18

1M ago33:18

33:18

Award-winning author and journalist Simon Kuper joined Brian Lott, CCO of Mubadala Investment Company, on stage at our spring seminar conference in Paris last spring. He described a new point of view on Paris, one of a dynamic city amid a huge transformation, beyond the role as an Olympic host city. In this episode, we’re bringing you this highly-r…

1
Optimizing PBC Pruritus Care in the Clinic 21:06

1M ago21:06

21:06

In this episode, Stuart C. Gordon, MD, FACP, FACG, AGAF, FAASLD; Marlyn J. Mayo, MD; and Brenda Remo discuss strategies for optimizing PBC pruritus care in the clinic setting. Listen to their conversation on how important it is to ask patients about their pruritus, validate their symptoms and feelings, and offer treatment options framed with realis…

1
The Patient Experience With Cholestatic Pruritus in PBC 13:05

1M ago13:05

13:05

In this episode, Stuart C. Gordon, MD, FACP, FACG, AGAF, FAASLD; Marlyn J. Mayo, MD; and Brenda Remo discuss the patient experience with cholestatic pruritus in PBC. Listen to their conversation on how people describe the experience of cholestatic pruritus, the extent to which pruritus negatively affects quality of life, and the importance of educa…

1
How to Make Depression Care an Integral Part of HIV Care 50:58

2M ago50:58

50:58

In this episode, Bradley N. Gaynes, MD, MPH, and Glenn J. Treisman, MD, PhD, discuss the importance of screening, diagnosing, and treating depression in people living with HIV. They illustrate their discussion through a patient case and provide strategies for accomplishing this, including creation of a virtual network and employment of measurement-…

1
Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs 34:45

2M ago34:45

34:45

In this episode, Dr Virginia Kaklamani moderates a discussion with Dr Aditya Bardia and Dr Sarah Sammons answering audience questions on the latest data on the use of oral SERDs therapy, including how to incorporate this new class of therapy into treatment plans for patients with HR+/HER2- breast cancer. Presenters: Virginia Kaklamani, MD, DSc Prof…

1
Current Clinical Practice and NCCN Guidelines for CLL/SLL 31:33

2M ago31:33

31:33

In this podcast episode, Farrukh Awan, MD, Jeremy S. Abramson, MD, MMSc, and Shuo Ma, MD, PhD, discuss real-world patient cases and how to align current clinical practice with the NCCN guidelines for CLL/SLL, including: Prognostic variables when deciding between regimens Role of MRD in CLL Results from the phase II CAPTIVATE trial Choosing among th…

1
Olympic Parallels for Communicators: A Conversation with Paris 2024 CEO Étienne Thobois 30:25

2M ago30:25

30:25

Earlier this year, Page Up Chair Umayma Abubakar had the opportunity to interview Étienne Thobois, the Paris 2024 CEO, about the upcoming 2024 Paris Olympic and Paralympic Games at our Spring Seminar. For this episode, we bring you their conversation, which covered topics ranging from stakeholder engagement, project management and cross-cultural co…

1
Congress to Clinic: Expert Takeaways on Emerging Data for MPNs 28:35

2M ago28:35

28:35

In this episode, listen to Dr Brady L. Stein share his clinical insights and takeaways on new data for myeloproliferative neoplasms (MPNs) presented at the 2024 ASCO Annual Meeting and the EHA 2024 Congress including: Long-term survival adjusted for treatment crossover in patients with myelofibrosis (MF) treated with momelotinib vs danazol in the M…

1
Navigating IgA Nephropathy: Insights From a Patient With Lived Experience 21:53

2M ago21:53

21:53

In this CCO Nephrology podcast episode, hear from Kelly Chen, a nephrology nurse practitioner and patient living with IgA nephropathy, as she discusses her experiences with Dr Pietro Canetta, Associate Professor of Medicine at Columbia University and expert in glomerular diseases. Episode outline: Seeking and obtaining an IgAN diagnosis Patient sel…

1
CELMoDs: Spotlight on Therapeutic Approaches Targeting Protein Degradation Pathways 24:23

2M ago24:23

24:23

In this podcast episode, Julio C. Chavez, MD, MS, and Alan Skarbnik, MD, discuss the emerging role of CELMoDs in NHL care, including: Rationale for targeting CELMoDs in NHL Mechanism of action of CELMoDs Key studies and available efficacy and safety data with investigational CELMoDs in NHL Key ongoing clinical trials of CELMoDs in NHL Strategies to…

1
Experts Discuss the Role of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer 24:30

2M ago24:30

24:30

In this episode, Dr Joyce O’Shaughnessy moderates a discussion with Dr Sara Hurvitz and Dr Erica Mayer answering audience questions on the latest data on incorporating CDK4/6 inhibitors into treatment plans for patients with HR+/HER2- breast cancer. Topics in this podcast include: Evidence from the monarchE and NATALEE trials of adjuvant abemacicli…

1
Congress to Clinic: Expert Takeaways on Emerging Data for AML 25:21

2M ago25:21

25:21

In this episode, listen to Professor Eunice S. Wang, MD, share her clinical insights and takeaways on new data for acute myeloid leukemia (AML) presented at the 2024 ASCO annual meeting and the EHA 2024 Congress including: Data from the prospective, single-center phase Ib/II study of FLAG-IDA plus venetoclax in newly diagnosed or relapsed/refractor…

1
Congress to Clinic: Expert Takeaways on Emerging Data for MDS 19:19

2M ago19:19

19:19

In this episode, listen to Professor Courtney DiNardo, MD, MSCE, share her clinical highlights and clinical takeaways on new data for myelodysplastic syndromes (MDS) presented at the 2024 ASCO annual meeting and the EHA 2024 Congress including: COMMANDS trial of luspatercept in transfusion-dependent, erythropoietin stimulating agent–naive, very low…

1
Humanity Creates Value 45:09

2M ago45:09

45:09

In this episode, we explore the findings from IRG’s new research, which Page participated in, and their implications for Chief Communications Officers. We also hear Dana Holmes's practical experience at Blue Cross Blue Shield and Marc de Swaan Arons's insights from the Institute for Real Growth.저자 Page Society

1
Managing Weight Gain on ART 24:00

2M ago24:00

24:00

In this episode, Cristina Mussini, MD,and William R. Short, MD, MPH, FIDSA,discuss the potential role of ART in weight change among people living with HIV. Listen to their conversation on whether ART switch can lead to weight loss after weight gain and how to counsel people living with HIV on weight loss options, including lifestyle modifications a…

1
Guest episode, The Specifics Matter: Reinforcing Credibility in a Multi-Stakeholder Environment 45:10

3M ago45:10

45:10

Please enjoy this episode of G&S Communications' podcast Building Brand Gravity titled The Specifics Matter: Reinforcing Credibility in a Multi-Stakeholder Environment. It featured a wide-ranging conversation with Page Up members Steve Halsey and Rob Jekielek with our very own Eliot Mizrachi.저자 Page Society

1
A Triumphant Return: Welcoming People Back to HIV Care 12:33

3M ago12:33

12:33

In this episode, Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD, uses a case study to illustrate why patients living with HIV may disengage with their care and how best to reengage them once they present at the clinic, including discussion of: The valid reasons patients have for disengaging with their HIV care Why the return to care should be c…

1
Mpox: Making Vaccination Routine 13:49

3M ago13:49

13:49

In this second podcast of our series, hear expert faculty explore the CDC recommendations for mpox protection and discuss how vaccination can lead to immunologic equity. Topics include: Should we consider mpox an STI? What strategies can be used to improve mpox vaccination and overcome the challenges of vaccine implementation? Can mpox vaccine be c…

1
Mpox Infection and Prevention 19:41

3M ago19:41

19:41

Hear expert faculty answer common questions about the risk, impact, and recommendations for protection against mpox, including: Why is mpox relevant to clinical practice? Who is at highest risk for mpox? How is mpox transmitted, and what are the clinical manifestations and complications of mpox infections? What are current ACIP recommendations for …

1
How Plain Language Improves Workplace Health and Safety 14:27

3M ago14:27

14:27

When employers commit to using plain language, they make it easier for workers to do their jobs. They also help to support a more inclusive workplace. In this episode, we talk with plain language expert Jocelyn Pletz about how clear and simple communication can improve health and safety. Released: June 5, 2024 File Size: 8.2 MB Length: 14:26 minute…

1
Breaking Down Key PrEP Barriers: Patient and Regimen-Based Factors 11:50

3M ago11:50

11:50

In this episode, Roger Bedimo, MD, MS, FACP, examines patient and regimen-based PrEP barriers and discusses practical interventions to support PrEP adherence in key populations. Topics covered include: Individual and community perspectives on PrEP barriers Key barriers by principal populations Strategies to support PrEP delivery PrEP options for ke…

1
Actively Countering Health Disparities to Improve PrEP Uptake 15:09

3M ago15:09

15:09

In this episode, Roger Bedimo, MD, MS, FACP, discusses strategies to overcome health disparities to improve PrEP uptake, including: Targeting key populations that would benefit from PrEP but have low rates of uptake, such as transgender women and people who inject drugs Addressing intersectionality Overcoming implicit bias Addressing PrEP inequity …

1
Addressing Provider and Structural PrEP Barriers 14:40

3M ago14:40

14:40

In this episode, Roger Bedimo, MD, MS, FACP, examines provider-based and structural PrEP barriers and discusses practical methods for healthcare professionals to overcome these challenges. Topics covered include: Potential provider barriers to prescribing PrEP Strategies to facilitate conversations about PrEP Addressing the gap in PrEP provider tra…

1
Leveraging the Airwaves 32:44

4M ago32:44

32:44

In this special episode of the New CCO, Jesse Betend, our longtime producer, flips the script on Eliot. Together, they dive deep into the history of the New CCO Podcast, and recount some of the more profound lessons they've learned.저자 Page Society

1
Proactively Considering if Each Person Is on the Right HIV ART Regimen for Them 21:26

4M ago21:26

21:26

In this episode, Tristan J. Barber, MA, MD, FRCP, and Roger Bedimo, MD, MS, FACP, help you decide whether and how to modify ART in virologically suppressed individuals by critically appraising whether using newer agents may improve their treatment satisfaction. Listen to their conversation about their own approaches to evaluating whether each perso…

들어볼 가치가 있는 팟캐스트

CCO 팟 캐스트

들어볼 가치가 있는 팟캐스트

빠른 참조 가이드